• Explore /
  • Poster
  • / Development and validation of a tumor tissue based multivariate biomarker for predicting angiogenesis inhibitor clinical benefit in renal cell carcinoma (RCC).

Development and validation of a tumor tissue based multivariate biomarker for predicting angiogenesis inhibitor clinical benefit in renal cell carcinoma (RCC).

Abstract Poster

Authors

Sachdev Thomas, I

Sachdev P. Thomas

Kaiser Permanente, Vallejo, CA

Sachdev P. Thomas , Ulka N. Vaishampayan , Bryan Johnson , Laura Elaine Lamb , Jonathan Mowers , Benjamin J. Bulen , Nickolay A. Khazanov , Daniel H. Hovelson , Kat Kwiatkowski , Daniel R. Rhodes , Scott A. Tomlins

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT03061305

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 467)

DOI

10.1200/JCO.2024.42.4_suppl.467

Abstract #

467

Poster Bd #

K8

Abstract Disclosures

Similar Posters

First Author: Patrick Bolan

First Author: Shubham Pant

First Author: Camila Nassif Martins Ferreira

First Author: Jeffrey Thomas Yorio